Guardant Health
GH
#3559
Rank
C$4.18 B
Marketcap
$34.03
Share price
-1.18%
Change (1 day)
-7.87%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Operating Margin for Guardant Health (GH)

Operating Margin as of September 2024 (TTM): -76.15%

According to Guardant Health 's latest financial reports and stock price the company's current Operating Margin is -76.15%. At the end of 2023 the company had an Operating Margin of -84.90%.

Operating Margin history for Guardant Health from 2018 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2023-84.90%-41.6%
2022-145.36%41.27%
2021-102.89%19.98%
2020-85.76%163.69%
2019-32.52%-65%
2018-92.92%-44.34%
2017-166.96%-8.62%
2016-182.71%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
-21.34%-71.98%๐Ÿ‡บ๐Ÿ‡ธ USA
-1.54%-97.98%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.